HCW Biologics Inc. is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases. The firm considers age-related low-grade chronic inflammation as a contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. The company was founded by Hing C. Wong on April 2, 2018 and is headquartered in Miramar, FL.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
36
Frequently Asked Questions
What is Market Cap of HCW Biologics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. HCW Biologics Inc market cap is $10.54M.
What is the 52-week high for HCW Biologics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. HCW Biologics Inc 52 week high is $100.80 as of September 16, 2025.
What is the 52-week low for HCW Biologics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. HCW Biologics Inc 52 week low is $2.77 as of September 16, 2025.
What is HCW Biologics Inc stock price today?
HCW Biologics Inc stock price today is $4.19.
What was HCW Biologics Inc stock price yesterday?
HCW Biologics Inc stock price yesterday was $4.90.
What is the PE ratio of HCW Biologics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. HCW Biologics Inc’s P/E ratio is -0.30.
What is the Price-to-Book ratio of HCW Biologics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. HCW Biologics Inc P/B ratio is -202.3957.
What is the 50-day moving average of HCW Biologics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. HCW Biologics Inc 50-day moving average is $4.43.